nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.02.2009 | Case Report

Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases

verfasst von: Hussein S. Qublan, Zakarya Beni-Merei, Mohamad Megdadi, Gassan Al-Quraan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

This report is to illustrate two cases of ovarian hyperstimulation syndrome following the sole administration of injectable mid-luteal gonadotropin-releasing hormone agonists (triptorelin) for pituitary down-regulation. Both women underwent egg retrieval, and despite the transfer of good quality embryos, no pregnancy was achieved. The possible mechanism and management of the condition were discussed.

Lanzone A, Apa R, Fulghesu AM et al (1989) LH surge induction by GnRH-agonist at the time of ovulation. Gynecol Endocrinol 3:213–220PubMedCrossRef

Gonen Y, Balakier H, Powell W, Casper RF (1990) Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 71:918–922PubMed

Yeh J, Barbieri RL, Ravnikar VA (1989) Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression. J In Vitro Fertil Embryo Transf 6:261–263CrossRef

Parinaud J, Cohen K, Oustry P, Perineau M, Monrozies X, Reme JM (1992) Influence of ovarian cysts on the results of in vitro fertilization. Fertil Steril 58:1174–1177PubMed

Droesch K, Barbieri RL (1994) Ovarian hyperstimulation syndrome associated with the use of the gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 62:189–90PubMed

Weissman A, Barash A, Shapiro H, Casper RF (1998) Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadortophin releasing hormone. Hum Reprod 13:3421–3424PubMedCrossRef

Letterie GS (2000) Ovarian hyperstimulation caused by a gonadotropin agonist. Am J Obstet Gynecol 183:747CrossRef

Khalaf Y, Anderson H, Taylor A, Braude P (2000) Two rare events in one patient undergoing assisted conception: empty follicle syndrome and ovarian hyperstimulation with the sole administration of gonadotropin-releasing hormone agonist. Fertil Steril 73:171–172PubMedCrossRef

Brett S, Yong PYK, Thong KJ (2001) Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Nafarelin) as a complication of in vitro fertilization treatment. J Assist Reprod Genet 18:353–356PubMedCrossRef

10.

Qublan HS, Amarin ZO, Tahat YA, Smadi ZS, Kilani M (2006) Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Human Reprod 21:640–644CrossRef

11.

Feldburg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA (1989) Ovarian cyst formation: a complication of gonadotropin-releasing hormone agonist therapy. Fertil Steril 51:42–44

12.

Jenkins JM, Davies DW, Anthony F, Wood P, Gadd SG, Waston RH, Masson GM (1992) The detrimental influence of functional ovarian cyst during in-vitro fertilization cycles. Human Reprod 7:776–780

13.

Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN (1995) Gonadotropin-releasing hormone receptor gene expression in human ovary and granulose-lutein cells. J Clin Endocrinol Metab 80:430–434PubMedCrossRef

14.

Penzias AS, Lee G, Seifer DB, Shamma FN, DeCherney AH, Reindollar RH, Jones EE (1994) Aberrant estradiol flare despite gonadotropin-releasing hormone-agonist induced suppression is associated with impaired implantation. Fertil Steril 61:558–560PubMed

15.

Andersen CY, Humaidan P, Ejdrup HB, Bungum L, Grondahl ML, Westergaard LG (2006) Hormonal characteristics of follicular fluid from women receiving either GnRH agonist or HCG for ovulation induction. Hum Reprod 21:2126–2130PubMedCrossRef

Titel: Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases
verfasst von: Hussein S. Qublan
Zakarya Beni-Merei
Mohamad Megdadi
Gassan Al-Quraan
Publikationsdatum: 01.02.2009
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 2/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-008-0675-7

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2009

Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature

Can pentoxifylline improve the sperm motion and ICSI success in the primary ciliary dyskinesia?

Bilateral dermoid cysts of the ovary in a pregnant woman: case report and review of the literature

Retained foetal bones: an intrauterine cause of chronic pelvic pain

Tumor markers in mature cystic teratomas of the ovary

Psoas abscess in obstetrics

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie